Body composition variables as predictors of NAFLD by ultrasound in obese children and adolescents

BMC Pediatrics

Volumn 14, Issue 1, 2014, Pages

  Monteiro, Paula A ^a   de Moura Mello Antunes, Barbara ^a   Silveira, Loreana S ^a   Christofaro, Diego G D ^a   Fernandes, Rômulo A ^a   Freitas Junior, Ismael F ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Adolescents; Body composition; Children; Fatty liver; Obesity

Indexed keywords

ADOLESCENT; BODY COMPOSITION; CHILD; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; MALE; OBESITY; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; WAIST CIRCUMFERENCE;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; CHILD; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FAT MASS; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PEDIATRICS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SENSITIVITY AND SPECIFICITY; TRUNK FAT MASS; WAIST CIRCUMFERENCE;

EID: 84892957568     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-14-25     Document Type: Article

References (31)

1. Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg 2011, 24:205-210. 10.1055/s-0031-1295684, 3311487, 23204935.
2. Liu Q, Bengmark S, Qu S. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD). Lipids Health Dis 2010, 9:42. 10.1186/1476-511X-9-42, 2873482, 20426802.
3. Leamy AK, Egnatchik RA, Young JD. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 2013, 52:165-174. 10.1016/j.plipres.2012.10.004, 3868987, 23178552.
4. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010, 11:11-18. 10.1111/j.1467-789X.2009.00623.x, 19656312.
5. Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev 2004, 5:27-42. 10.1111/j.1467-789X.2004.00126.x, 14969505.
6. Bramlage KS, Bansal V, Xanthakos SA, Kohli R. Fatty liver disease in children--what should one do?. Indian J Pediatr 2013, 80(Suppl 1):S109-S114.
7. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34(3):274-285. 10.1111/j.1365-2036.2011.04724.x, 21623852.
8. Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, et al. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 2013, 37:392-400. 10.1111/apt.12186, 23278163.
9. Pereira AZ, Marchini JS, Carneiro G, Zanella MT. Ultrasound evalution f obesity: fat and muscle thickness, and visceral fat. Int J Nutrol 2012, 5:71-73.
10. Wilson JP, Fan B, Shepherd JA. Total and regional body volumes derived from dual-energy X-ray absorptiometry output. J Clin Densitom 2012, 12:1-6.
11. Lindbäck SM, Gabbert C, Johnson BL, Smorodinsky E, Sirlin CB, Garcia N, et al. Pediatric nonalcoholic fatty liver disease: a comprehensive review. Adv Pediatr 2010, 57:85-140. 10.1016/j.yapd.2010.08.006, 21056736.
12. Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, et al. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int 2010, 30:1189-1196. 10.1111/j.1478-3231.2010.02300.x, 20602679.
13. Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: metaregression analysis of prospective studies. Eur Heart J 2007, 28:850-856. 10.1093/eurheartj/ehm026, 17403720.
14. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. Bmj 2000, 320:1240-1243. 10.1136/bmj.320.7244.1240, 27365, 10797032.
15. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual 1988, 177. Champaign, Illinois: Human Kinetics.
16. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents. JAMA 2012, 307:483-490. 10.1001/jama.2012.40, 22253364.
17. Saadeh S, Younossi ZM, Reme EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol 2002, 123:745-750.
18. Ribeiro-Filho FF, Faria AN, Azjen S, Zanella MT, Ferreira SRG. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 2003, 11:1488-1494. 10.1038/oby.2003.199, 14694213.
19. Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescentes. Pediatr Diabetes 2009, 10(1):5-13. 10.1111/j.1399-5448.2008.00450.x, 18721166.
20. Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer W, et al. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009, 94:3872-3881. 10.1210/jc.2009-1125, 19773396.
21. Patton HM, Yates K, Unalp-Arida A, Behling CA, Huang TK, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol 2010, 105:2093-2102. 10.1038/ajg.2010.152, 3070291, 20372110.
22. Schwimmer JB, PPardee PE, Lavine JE, Blumkin AKB, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008, 118:277-283. 10.1161/CIRCULATIONAHA.107.739920, 2996820, 18591439.
23. Hsu E, Murray K. " Is nonalcoholic fatty liver disease in children the same disease as in adults?" Clin Liver Dis 2012, 16:587-598. 10.1016/j.cld.2012.05.004, 22824482.
24. Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2008, 28:13-24. 10.1111/j.1365-2036.2008.03703.x, 18397387.
25. Santos RR, Cotrim HP. Relevância das medidas antropométricas na avaliação de pacientes com doença hepática gordurosa não alcoólica. Rev Bras Nutr Clín 2006, 21:229-232.
26. Damaso AR, Do Prado WL, De Piano A, Tock L, Caranti DA, Lofrano MC, et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis 2008, 40:132-139. 10.1016/j.dld.2007.09.009, 18082476.
27. Chiloiro M, Riezzo G, Chiarappa S, Correale M, Guerra V, Amati L, et al. Relationship among fatty liver, adipose tissue distribution and metabolic profile in moderately obese children: an ultrasonographic study. Curr Pharm Des 2008, 14:2693-2698. 10.2174/138161208786264197, 18991688.
28. Lin YC, Chang PF, Yeh SJ, Liu K, Chen HC. Risk factors for liver steatosis in obese children and adolescents. Pediatr Neonatol 2010, 51(3):149-154. 10.1016/S1875-9572(10)60028-9, 20675238.
29. Sundaram SS, Zeitler P, Nadeau K. The metabolic syndrome and nonalcoholic fatty liver disease in children. Curr Opin Pediatr 2009, 21:529-535. 10.1097/MOP.0b013e32832cb16f, 3073840, 19444112.
30. José R, Fernández JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American. European-Am, and Mexican-Am Child and adolescents 2004, 145(4):439-444.
31. Deboer MD. Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab 2011, 6:279-289. 10.1586/eem.11.17, 3105461, 21643518.